Skip to main content
Erschienen in: Clinical Rheumatology 11/2017

24.08.2017 | Original Article

Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus

verfasst von: Hyoun-Ah Kim, Ju-Yang Jung, Chang-Hee Suh

Erschienen in: Clinical Rheumatology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) have been investigated as disease activity markers for systemic lupus erythematosus (SLE). Hence, we investigated the clinical significance of these parameters in diagnosing infection in patients with SLE. In total, 120 patients with SLE, who were admitted to hospital due to disease flares or infection, were recruited for the study. Of the 120 patients, 60 had a concurrent infection (SLE with infection), while the remaining 60 patients were admitted with a flare without any evidence of infection (SLE with flare). NLR was higher in the patients with SLE with infection, compared to patients with SLE with flare (14.2 ± 15.4 versus 3.3 ± 2.2, p < 0.001). Additionally, PLR was higher in the SLE with infection group than in the SLE with flare group (357.7 ± 350.1 versus 231.7 ± 152.9, p = 0.012), but not MLR. In the SLE with infection group, C-reactive protein (CRP) levels positively correlated with NLR and PLR. NLR with a cut-off value of 5.70 and an area under the curve (AUC) of 0.872 indicated good sensitivity (75%) and specificity (90%), for the diagnosis of SLE with infection. CRP with a cut-off value of 1.28 mg/dL (AUC 0.942) showed the sensitivity (93.3%) and specificity (91.7%). NLR with a cut-off value of 5.70 and CRP with a cut-off value of 1.28 mg/dL showed the increased specificity (98.3%) than only CRP, but not significant. NLR could be a good additive marker for diagnosing infection in patients with SLE.
Literatur
1.
Zurück zum Zitat Rigante D, Mazzoni MB, Esposito S (2014) The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev 13:96–102CrossRefPubMed Rigante D, Mazzoni MB, Esposito S (2014) The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev 13:96–102CrossRefPubMed
2.
Zurück zum Zitat Navarra SV, Leynes MS (2010) Infections in systemic lupus erythematosus. Lupus 19:1419–1424CrossRefPubMed Navarra SV, Leynes MS (2010) Infections in systemic lupus erythematosus. Lupus 19:1419–1424CrossRefPubMed
3.
Zurück zum Zitat Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 46:1487–1491CrossRef Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology (Oxford) 46:1487–1491CrossRef
4.
Zurück zum Zitat Ospina FE, Echeverri A, Zambrano D, Suso JP, Martinez-Blanco J, Canas CA, Tobon GJ (2017) Distinguishing infections vs flares in patients with systemic lupus erythematosus. Rheumatology (Oxford) 56(suppl_1):i46–i54 Ospina FE, Echeverri A, Zambrano D, Suso JP, Martinez-Blanco J, Canas CA, Tobon GJ (2017) Distinguishing infections vs flares in patients with systemic lupus erythematosus. Rheumatology (Oxford) 56(suppl_1):i46–i54
5.
Zurück zum Zitat Gao J, Zhang L, Zhang X, Zhao SL, Liu SY, Xing LH (2016) Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus. J Huazhong Univ Sci Technolog Med Sci 36:653–658CrossRefPubMed Gao J, Zhang L, Zhang X, Zhao SL, Liu SY, Xing LH (2016) Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus. J Huazhong Univ Sci Technolog Med Sci 36:653–658CrossRefPubMed
6.
Zurück zum Zitat Kim HA, Jeon JY, An JM, Koh BR, Suh CH (2012) C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin. J Rheumatol 39:728–734CrossRefPubMed Kim HA, Jeon JY, An JM, Koh BR, Suh CH (2012) C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin. J Rheumatol 39:728–734CrossRefPubMed
7.
Zurück zum Zitat Pyo JY, Park JS, Park YB, Lee SK, Ha YJ, Lee SW (2013) Delta neutrophil index as a marker for differential diagnosis between flare and infection in febrile systemic lupus erythematosus patients. Lupus 22:1102–1109CrossRefPubMed Pyo JY, Park JS, Park YB, Lee SK, Ha YJ, Lee SW (2013) Delta neutrophil index as a marker for differential diagnosis between flare and infection in febrile systemic lupus erythematosus patients. Lupus 22:1102–1109CrossRefPubMed
8.
Zurück zum Zitat Suh CH, Jeong YS, Park HC, Lee CH, Lee J, Song CH, Lee WK, Park YB, Song J, Lee SK (2001) Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol 19:191–194PubMed Suh CH, Jeong YS, Park HC, Lee CH, Lee J, Song CH, Lee WK, Park YB, Song J, Lee SK (2001) Risk factors for infection and role of C-reactive protein in Korean patients with systemic lupus erythematosus. Clin Exp Rheumatol 19:191–194PubMed
9.
Zurück zum Zitat Suh CH, Chun HY, Ye YM, Park HS (2006) Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Clin Immunol 119:291–296CrossRefPubMed Suh CH, Chun HY, Ye YM, Park HS (2006) Unresponsiveness of C-reactive protein in the non-infectious inflammation of systemic lupus erythematosus is associated with interleukin 6. Clin Immunol 119:291–296CrossRefPubMed
10.
Zurück zum Zitat Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, Haznedaroglu S, Goker B (2016) The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal 30:597–601CrossRefPubMed Mercan R, Bitik B, Tufan A, Bozbulut UB, Atas N, Ozturk MA, Haznedaroglu S, Goker B (2016) The association between neutrophil/lymphocyte ratio and disease activity in rheumatoid arthritis and ankylosing spondylitis. J Clin Lab Anal 30:597–601CrossRefPubMed
11.
Zurück zum Zitat Yang W, Wang X, Zhang W, Ying H, Xu Y, Zhang J, Min Q, Chen J (2017) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis. Clin Chim Acta 465:11–16CrossRefPubMed Yang W, Wang X, Zhang W, Ying H, Xu Y, Zhang J, Min Q, Chen J (2017) Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio are 2 new inflammatory markers associated with pulmonary involvement and disease activity in patients with dermatomyositis. Clin Chim Acta 465:11–16CrossRefPubMed
12.
Zurück zum Zitat Wu Y, Chen Y, Yang X, Chen L, Yang Y (2016) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol 36:94–99CrossRefPubMed Wu Y, Chen Y, Yang X, Chen L, Yang Y (2016) Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol 36:94–99CrossRefPubMed
13.
Zurück zum Zitat Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26:372–376CrossRefPubMed Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z, Zhong R (2016) Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol 26:372–376CrossRefPubMed
14.
Zurück zum Zitat Li L, Xia Y, Chen C, Cheng P, Peng C (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026–11031PubMedPubMedCentral Li L, Xia Y, Chen C, Cheng P, Peng C (2015) Neutrophil-lymphocyte ratio in systemic lupus erythematosus disease: a retrospective study. Int J Clin Exp Med 8:11026–11031PubMedPubMedCentral
15.
Zurück zum Zitat Farah R, Ibrahim R, Nassar M, Najib D, Zivony Y, Eshel E (2017) Neutrophil lymphocyte ratio better addition to CRP than CD64 index as marker for infection in COPD. Panminerva Med 59:203–209PubMed Farah R, Ibrahim R, Nassar M, Najib D, Zivony Y, Eshel E (2017) Neutrophil lymphocyte ratio better addition to CRP than CD64 index as marker for infection in COPD. Panminerva Med 59:203–209PubMed
16.
Zurück zum Zitat Han SY, Lee IR, Park SJ, Kim JH, Shin JI (2016) Usefulness of neutrophil-lymphocyte ratio in young children with febrile urinary tract infection. Korean J Pediatr 59:139–144CrossRefPubMedPubMedCentral Han SY, Lee IR, Park SJ, Kim JH, Shin JI (2016) Usefulness of neutrophil-lymphocyte ratio in young children with febrile urinary tract infection. Korean J Pediatr 59:139–144CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277CrossRefPubMed
18.
Zurück zum Zitat Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum 35:630–640CrossRefPubMed
19.
Zurück zum Zitat Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S (2016) Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study. Mediat Inflamm 2016:8191254 Liu X, Shen Y, Wang H, Ge Q, Fei A, Pan S (2016) Prognostic significance of neutrophil-to-lymphocyte ratio in patients with sepsis: a prospective observational study. Mediat Inflamm 2016:8191254
20.
Zurück zum Zitat Bozbay M, Uyarel H (2015) Neutrophil-to-lymphocyte ratio: a novel and simple prognostic marker for infective endocarditis. J Crit Care 30:822CrossRefPubMed Bozbay M, Uyarel H (2015) Neutrophil-to-lymphocyte ratio: a novel and simple prognostic marker for infective endocarditis. J Crit Care 30:822CrossRefPubMed
21.
Zurück zum Zitat Yilmaz H, Cakmak M, Inan O, Darcin T, Akcay A (2015) Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis? Ren Fail 37:225–229CrossRefPubMed Yilmaz H, Cakmak M, Inan O, Darcin T, Akcay A (2015) Can neutrophil-lymphocyte ratio be independent risk factor for predicting acute kidney injury in patients with severe sepsis? Ren Fail 37:225–229CrossRefPubMed
22.
Zurück zum Zitat Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S (2012) Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 5:2CrossRefPubMedPubMedCentral Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S (2012) Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med 5:2CrossRefPubMedPubMedCentral
Metadaten
Titel
Usefulness of neutrophil-to-lymphocyte ratio as a biomarker for diagnosing infections in patients with systemic lupus erythematosus
verfasst von
Hyoun-Ah Kim
Ju-Yang Jung
Chang-Hee Suh
Publikationsdatum
24.08.2017
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 11/2017
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-017-3792-5

Weitere Artikel der Ausgabe 11/2017

Clinical Rheumatology 11/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.